跳至主要内容
临床试验/NCT03545516
NCT03545516Unknown2 期

Randomized Control Trial for an Opioid Free Analgesic Pathway Post Cesarean Delivery

Richmond University Medical Center1 个研究点 分布在 1 个国家目标入组 540 人开始时间: 2018年9月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
540
试验地点
1
主要终点
Total number of opioid free Cesarean deliveries

研究概览

简要总结

This study will investigate the effect of three types of wound infiltration on post Cesarean opioid analgesia consumption when used in conjunction with an opioid free postoperative analgesia pathway.

详细描述

The subjects that meet the inclusion criteria of the study will be randomized preoperatively into three arms following a 1:1:1 ratio. During the intraoperative course one of three combinations of wound infiltration will be administered to subjects prior to the closure of the surgical incision. Subjects in Group I will receive a placebo of normal saline. Subjects in Group II will receive bupivacaine alone. Subjects in Group III will receive both bupivacaine and dexmedetomidine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All scheduled Cesarean deliveries with intrathecal or epidural anesthesia

排除标准

  • Emergency Cesarean deliveries
  • Multifetal gestation
  • Subjects <18 years old
  • Subjects belonging to a vulnerable population (including subjects with a known opioid addiction, subjects with a history of mental illness and prisoners)
  • Cesarean delivery with general anesthesia
  • Known allergy or hypersensitivity to any of the study medications
  • Subjects that can't comprehend the visual analog scale for quantitative pain assessment

研究组 & 干预措施

Placebo

Placebo Comparator

Wound infiltration with a placebo

干预措施: Placebo (Drug)

Bupivacaine

Experimental

Wound Infiltration with 20 mL (150mg) of 0.75% bupivacaine diluted with 5 mL of normal saline to give a 25 mL

干预措施: Bupivacaine (Drug)

Bupivacaine and Dexmedetomidine

Experimental

Wound Infiltration with 20 mL (150mg) of 0.75% bupivacaine and 1.5 mcg/kg of dexmedetomidine will be diluted with normal saline to make 25 mL of solution .

干预措施: Bupivacaine (Drug)

Bupivacaine and Dexmedetomidine

Experimental

Wound Infiltration with 20 mL (150mg) of 0.75% bupivacaine and 1.5 mcg/kg of dexmedetomidine will be diluted with normal saline to make 25 mL of solution .

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Total number of opioid free Cesarean deliveries

时间窗: 1 year

Measure the number of Cesarean deliveries that did not require opioid analgesia during the postoperative course

次要结局

  • Complications from procedures(0-14 days)
  • Side effects/Adverse reactions(0-14 days)
  • Breast feeding capacity(0-14 days)
  • Time to first rescue analgesia(0 hour post-cesarean to time rescue analgeisa is administered])
  • Total opioid consumption(0-14 days)
  • Postoperative hospital stay(0-14days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nisha Lakhi, MD

Research Director

Richmond University Medical Center

研究点 (1)

Loading locations...

相似试验